Welcome to HitGen


HitGen offers comprehensive drug discovery services (target validation, hit identification, hit-to-lead, lead optimization, preclinical studies, IND filing and clinical development) centered around our world-leading DNA-encoded compound library (DEL) technologies and Fragment-based drug discovery (FBDD) to our customers. We have flexible business models, including single capability-based Fee For Service (FFS), Full-time Equivalent (FTE), Integrated Drug Discovery Service (IDDS), risk-sharing projects and collaborative vertures. 

Services display

Thanks for reading!

For more details on how we can advance your innovative drug discovery projects
By submitting your information, you acknowledge having received, read and understood our Privacy Notice as made available above.

We use cookies to provide a better web experience.
By using our site, you acknowledge our use of cookies and please read our Cookie Notice for More information